RAD-140 (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "RAD-140" in German language version.

refsWebsite

Global rank German rank

5doi.org

2^nd place

3^rd place

2nih.gov

4^th place

7^th place

2fda.gov

447^th place

751^st place

1who.int

195^th place

255^th place

1clinicaltrials.gov

5,225^th place

2,461^st place

1ellipses.life

low place

1wada-ama.org

9,542^nd place

low place

clinicaltrials.gov (Global: 5,225^th place; German: 2,461^st place)

Phase 1, First-in-Human Study of RAD140 in Postmenopausal Women With Breast Cancer, auf clinicaltrials.gov

doi.org (Global: 2^nd place; German: 3^rd place)

Christopher P. Miller et al.: Design, Synthesis, and Preclinical Characterization of the Selective Androgen Receptor Modulator RAD140. In: ACS Medicinal Chemistry Letters. Band 2, Nr. 2, 2011, S. 124–129. doi:10.1021/ml1002508.
Erika Hamilton, Neelima Vidula, X. Cynthia, P. LoRusso, Rebecca G. Bagley, Ziyang Yu, Miriam Annett, Aaron Weitzman, Maureen G. Conlan, Amy Weise: Phase I dose escalation study of a selective androgen receptor modulator RAD140 in estrogen receptor positive (ER+), HER2 negative (HER2-) breast cancer (BC). In: Annals of Oncology. 2019, Band 30, S. v123. doi:10.1093/annonc/mdz242.038.
Zachary J. Solomon: Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications. In: Sexual Medicine Reviews. 7. Jahrgang, Nr. 1, 2019, S. 84–94, doi:10.1016/j.sxmr.2018.09.006, PMID 30503797 (englisch).
Ramesh Narayanan: Selective Androgen Receptor Modulators in Preclinical and Clinical Development. In: Nuclear Receptor Signaling. 15. Jahrgang, 2017, S. e001, doi:10.1621/nrs.06010, PMID 19079612 (englisch).
Ryan M. Van Wagoner: Chemical Composition and Labeling of Substances Marketed as Selective Androgen Receptor Modulators and Similar Substances. In: JAMA. 318. Jahrgang, Nr. 20, 2017, S. 2004–2010, doi:10.1001/jama.2017.17069 (englisch).

ellipses.life (Global: low place; German: low place)

Radius Health Divests RAD 140 Program to Ellipses Pharma (PDF), Radius Health Inc, 1. Oktober 2020.

fda.gov (Global: 447^th place; German: 751^st place)

FDA Warns of Use of Selective Androgen Receptor Modulators (SARMs) Among Teens, Young Adults. In: U.S. Food and Drug Administration. 26. April 2023, abgerufen am 22. Mai 2025 (englisch).
FDA In Brief: FDA warns against using SARMs in body-building products. In: U.S. Food and Drug Administration. 31. Oktober 2017, abgerufen am 20. Mai 2025 (englisch).

nih.gov (Global: 4^th place; German: 7^th place)

ncbi.nlm.nih.gov

Zachary J. Solomon: Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications. In: Sexual Medicine Reviews. 7. Jahrgang, Nr. 1, 2019, S. 84–94, doi:10.1016/j.sxmr.2018.09.006, PMID 30503797 (englisch).
Ramesh Narayanan: Selective Androgen Receptor Modulators in Preclinical and Clinical Development. In: Nuclear Receptor Signaling. 15. Jahrgang, 2017, S. e001, doi:10.1621/nrs.06010, PMID 19079612 (englisch).

wada-ama.org (Global: 9,542^nd place; German: low place)

WADA 2024 Prohibited List. In: World Anti-Doping Agency. Abgerufen am 22. Mai 2025 (englisch).

who.int (Global: 195^th place; German: 255^th place)

INN Recommended List 84. In: who.int. 9. September 2020, abgerufen am 22. Mai 2025 (englisch).

RAD-140 (German Wikipedia)

clinicaltrials.gov (Global: 5,225th place; German: 2,461st place)

doi.org (Global: 2nd place; German: 3rd place)

ellipses.life (Global: low place; German: low place)

fda.gov (Global: 447th place; German: 751st place)

nih.gov (Global: 4th place; German: 7th place)